The Vpr accessory protein of HIV-1 induces a response similar to that of DNA damage. In cells expressing Vpr, the DNA damage sensing kinase, ATR, is activated, resulting in G 2 arrest and apoptosis. In addition, Vpr causes rapid degradation of the uracil-DNA glycosylases UNG2 and SMUG1. Although several cellular proteins have been reported to bind to Vpr, the mechanism by which Vpr mediates its biological effects is unknown. Using tandem affinity purification and mass spectrometry, we identified a predominant cellular protein that binds to Vpr as the damage-specific DNAbinding protein 1 (DDB1). In addition to its role in the repair of damaged DNA, DDB1 is a component of an E3 ubiquitin ligase that degrades numerous cellular substrates. Interestingly, DDB1 is targeted by specific regulatory proteins of other viruses, including simian virus 5 and hepatitis B. We show that the interaction with DDB1 mediates Vpr-induced apoptosis and UNG2/SMUG1 degradation and impairs the repair of UV-damaged DNA, which could account for G 2 arrest and apoptosis. The interaction with DDB1 may explain several of the diverse biological functions of Vpr and suggests potential roles for Vpr in HIV-1 replication.
V
pr is a small nuclear accessory protein of HIV-1 and other lentiviruses that, when expressed in cells, causes G 2 cellcycle arrest and apoptosis. Although Vpr is not required for virus replication in vitro, it is well conserved in primary virus isolates and contributes to pathogenesis (1) . Whereas ⌬vpr SIV was found to be nearly as pathogenic as wild-type, a vpr/vpx double mutant was highly attenuated, suggesting an important and partially redundant role in pathogenesis (2) . Vpr is the only HIV-1 accessory protein to be specifically packaged into virions and localizes to the nucleus of infected cells. Several roles for Vpr in virus replication and pathogenesis have been proposed (reviewed in refs. 3 and 4) . It causes a modest increase in virion production (5) and may facilitate nuclear import of the preintegration complex (6) . Vpr has been found both to cause packaging of UNG2 (7) and to cause its proteasomal degradation (8) . Vpr activates the ataxia telangiectasia-mutated (ATM) and Rad3-related protein (ATR) (9) (10) (11) (12) (13) causing the phosphorylation of the ATR substrates Chk1 (10) and the histone 2A variant H2AX (11) , resulting in G 2 arrest. Vpr also induces BRCA-1 and GADD45a (14) and generates nuclear foci containing H2AX and BRCA-1 (11) . These phenotypes resemble that of DNA damage although Vpr itself does not seem to damage DNA.
Activation of ATR is the furthest activity upstream in the cell-cycle regulatory pathway known to be affected by Vpr, but this activity is not thought to be caused by a direct interaction. Several cellular binding partners for Vpr have been reported including UNG2, HSP70, HHR23A, p300, and VprBP (reviewed in ref. 15 ), but these interactions have not been shown to induce G 2 arrest or cause apoptosis. The identification of the immediate target of Vpr would provide valuable insight into its function. Using tandem affinity purification (TAP) coupled with mass spectrometry, we identified the damaged DNA-binding protein (DDB1) as a specific cellular binding partner for Vpr. The interaction with DDB1 mediates the proteasomal degradation of UNG2 and SMUG1, is required for Vpr-induced apoptosis, and prevents the cells from repairing UV damage. Interestingly, viruses such as simian virus 5 (SV5) and hepatitis B also target DDB1 (16) (17) (18) .
Results
Vpr Interacts with DDB1. To identify interacting cellular proteins, a TAP-tagged Vpr expression vector was generated in which tandem streptavidin and calmodulin-binding sites were linked to the N terminus of Vpr. The TAP-tagged Vpr was expressed in transiently transfected 293T cells and shown to be functional for G 2 arrest by DNA content profiling [supporting information (SI) Fig. 6 ]. Complexes of the tagged Vpr were purified from lysates of the transfected cells by TAP over streptavidin and calmodulin columns and the purified protein complexes were visualized by Coomassie staining after SDS/PAGE. Protein bands specific to the TAP-tagged Vpr (Fig. 1A) were excised and subjected to mass spectrometry. Two proteins were identified in the 100-kDa band: DDB1 and VprBP, a previously reported binding partner for Vpr that was affinity purified on a bacterially synthesized recombinant Vpr column (19) . In repeated analyses, we could not identify the 150-kDa protein.
To confirm the association of Vpr with DDB1 in cells, the complex was coimmunoprecipitated with DDB1 in transfected cell lysates. An HA-tagged Vpr (HA-Vpr) was expressed in HeLa cells and immunoprecipitated with anti-HA mAb. The coimmunoprecipitated DDB1 was detected on an immunoblot. DDB1 was found to specifically coimmunoprecipitate with Vpr (Fig. 1B) . DDB1 also coimmunoprecipitated with a myc-tagged SIV Vpr (Fig. 1C) . In addition, the complex was coimmunoprecipitated from HIV-1-infected T cells. For this analysis, CEMss cells were infected with replication-competent NL4-3 HIV-1 that encodes a HA-tagged Vpr or with ⌬vpr NL4-3 (Fig. 1D ).
Vpr Interacts with the DDB1-Cul4-Roc1 E3 Ubiquitin Ligase. DDB1 is a 128-kDa UV-damaged DNA-binding protein involved in nucleotide excision repair (NER) that forms a heterodimer with the 48-kDa protein DDB2 (17, 18) . Upon damage to DNA by UV light, the DDB1/DDB2 complex (UV-DDB) translocates to the nucleus where it binds with high affinity to UV-damaged DNA to mediate repair. In addition to its role in NER, DDB1 forms part of a ubiquitin ligase containing Cul4A and Roc1 that targets cell-cycle regulatory proteins such as Cdt1 and p27 kip for proteasomal degradation (20, 21) .
Vpr induces the degradation of UNG2 and SMUG1 in association with Cul4A (8) . To determine whether DDB1 might play a role in this degradation, we tested for the presence of a complex of Vpr with DDB1, Cul4A, and Roc1. 293T cells were cotransfected with HA-Vpr and myc-Cul4A expression vector. HA-Vpr was immunoprecipitated, and the coimmunoprecipitated DDB1, Cul4A, and Roc1 were detected on an immunoblot ( Fig. 2A) . The analysis confirmed the presence of a complex containing Vpr, DDB1, Cul4A, and Roc1.
To determine whether the interaction with Cul4A and Roc1 was mediated by the interaction of Vpr with DDB1, siRNA transfection was used to knockdown DDB1. DDB1 was knocked down with specific or control siRNA, and the next day the cells were transfected with myc-Cul4A with or without HA-Vpr. Vpr complexes were immunoprecipitated, and the coimmunoprecipitated DDB1, Cul4A, and Roc1 were detected on an immunoblot. siRNA knocked down DDB1 by 80-90% (Fig. 2B ). DDB1 knockdown prevented the association with Cul4A and Roc1. Complexes of Vpr with Cul4A and Roc1 were detected in control-transfected cells but not in those knocked down for DDB1. These findings demonstrated the dependence of DDB1 on formation of the complex with the Cul4A-Roc1 E3 ubiquitin ligase.
Identification of a Stable Vpr Point Mutant that Fails to Bind DDB1.
To probe the specificity of the interaction, a panel of mutated Vpr proteins was tested for DDB1 binding. HA-Vpr point mutants were expressed in transfected 293T cells and immunoprecipitated. The coimmunoprecipitated DDB1 was detected on an immunoblot. The majority of the mutants, including A30P, I70A, R80A, Q65A, H71G, and R85A were poorly expressed (Fig. 2C , second panel), a property that is typical of Vpr point mutants 
HA-Vpr HA-Vpr HA-Vpr HA-Vpr (our unpublished observations). Only L64P and W54R were stably expressed. Importantly, L64P was stably expressed but failed to interact efficiently with DDB1. The L64P mutant has been described by Jian and Zhao (22) , who previously showed that this mutant was particularly proapoptotic. Two mutants, H71G and R85A, were expressed at low levels but maintained their interaction with DDB1. W54R, a mutant that has been shown previously not to bind UNG2 (23), was stably expressed but maintained its interaction with DDB1. Two mutants, H71G and R85A, maintained their interaction with DDB1 despite their reduced expression. No conclusion could be drawn for A30P, Q65A, I70A, and R80A, which were poorly expressed.
Vpr Induces the DDB1-Cul4A-Roc1 Ubiquitin Ligase to Target UNG2 for Degradation. The association of Vpr with the DDB1-containing E3 ligase suggested that this complex might mediate the degradation of UNG2 and SMUG1. To determine whether Vpr binding to DDB1 was required for UNG2 degradation, we tested whether the DDB1-binding-defective Vpr mutant, L64P, could degrade UNG2. HA-UNG2 was expressed in cotransfected 293T cells with wild-type or L64P Vpr and detected on an immunoblot. The results showed that Vpr, but not L64P Vpr, caused a significant reduction in UNG2 expression (Fig. 3A) . To test whether Vpr-induced degradation of UNG2 depends on DDB1, we knocked down DDB1 and tested for Vpr-induced degradation of UNG2. Knockdown of DDB1 was efficient and specific ( Fig. 3B ) and prevented the Vpr-induced degradation of UNG2. Similar results were obtained with SMUG1 (data not shown). These findings suggested that the interaction with DDB1 is required for Vpr-induced degradation of UNG2 and SMUG1. We further knocked down Cul4 to determine whether it is involved in Vpr-induced UNG2 degradation. Cul4 knockdown with specific siRNA, but not control siRNA prevented Vprinduced UNG2 degradation (Fig. 3C) . We further tested the DDB1 mutant W561A that does not bind Cul4A (24) and found that it was impaired for Vpr-induced UNG2 degradation (Fig.  3D) . The effect was modest, probably because of the endogenous DDB1. Taken together, the results suggested that Vpr interacts with the DDB1-Cul4A-Roc1 E3 ubiquitin ligase to target UNG2 for proteasomal degradation.
Vpr Interferes with UV Damage-Induced Nuclear Localization of DDB1.
UV damage causes the DDB1/DDB2 complex to translocate to the nucleus (25, 26) . To determine whether Vpr might affect the translocation of DDB1 to the nucleus, HA-Vpr was expressed in transfected HeLa cells. The cells were exposed to UV light and subsequently Vpr and DDB1 were visualized by immunofluorescence. In unirradiated cells, Vpr localized to the nucleus (Fig.  4A) whereas DDB1 was present throughout the cell. In low dose UV irradiated cells (UV-B 30 J/m 2 ) without Vpr, DDB1 accumulated in the nucleus (cells lacking Vpr are shown in SI Fig. 7) . Expression of Vpr prevented the nuclear accumulation of DDB1 in cells exposed to low and high doses of UV light. Biochemical analysis of DDB1 localization confirmed these results. Cells were transfected with Vpr expression vector and then fractionated into nucleus and cytoplasm. Effective fractionation was confirmed by immunoblot quantitation of the nuclear protein, heterogeneous nuclear ribonucleoprotein C, and cytoplasmic protein, GAPDH (SI Fig. 8) . In unirradiated cells, Vpr was present in the nuclear fraction and DDB1 was in the cytoplasm (Fig. 4B) . UV irradiation caused DDB1 to accumulate in the nucleus but in the presence of Vpr, DDB1 remained in the cytoplasm. L64P Vpr did not affect DDB1 translocation to the nucleus. These data suggest that Vpr blocks the UV damage induced nuclear accumulation of DDB1.
Vpr Impairs DNA Repair. UV light causes the formation of cyclobutane pyrimidine dimers (CPD) and pyrimidinepyrimidone (6-4) photoproducts (6-4PP) (17, 18). To test whether the binding of Vpr to DDB1 might interfere with DNA repair, HeLa cells were transfected with Vpr expression vector and two days later UV irradiated. Resulting CPDs in the genomic DNA was then quantitated by ELISA. In control UV irradiated cells, UV light induced CPDs which were rapidly repaired (Fig. 4C) . In cells that expressed Vpr, CPDs remained relatively stable over the time course. To confirm that the repair was DDB1-mediated, the experiment was repeated in cells in which DDB1 was knocked down. In control cells, 80% of CPDs generated by UV irradiation were repaired within 24 h whereas, in cells expressing Vpr, repair was prevented. In cells in which DDB1 had been knocked down, the CPDs failed to be repaired (Fig. 4C Right) . These results suggested that Vpr interferes with DDB1-mediated repaired of UV-damaged DNA.
Vpr Prevents the Binding of DDB to UV-Damaged DNA. The impaired ability to repair UV-damaged DNA in the presence of Vpr could be caused by a failure of UV-DDB to bind to damaged DNA. To determine whether Vpr interfered with the ability of DDB1 to bind UV-damaged DNA, nuclear extracts were prepared from cells that expressed a transfected Vpr expression vector and incubated with a biotinylated UV irradiated DNA oligonucleotide. The DD-B:DNA complexes were detected by an electrophoretic mobility shift assay (EMSA). A shifted band was observed with the UV irradiated but not the unirradiated control oligonucleotide probe (Fig. 4D) . Nuclear extract from cells that expressed L64P Vpr or empty vector resulted in two bands on the EMSA. These bands were much weaker in cells that expressed Vpr. Addition of a 100 M excess of unlabeled CPD prevented the shift. We concluded that Vpr reduces the affinity of the UV-DDB complex for CPD containing DNA.
Vpr Disrupts the UV-DDB Complex. The DNA repair function of DDB1 requires the interaction with DDB2. To determine whether Vpr might block this association, we transfected 293T cells with Flag-DDB2 expression vector with or without HA-Vpr. Two days post transfection, DDB2 was immunoprecipitated and DDB1 that coimmunoprecipitated was detected on an immunoblot. In the absence of Vpr, DDB1 and DDB2 coimmunoprecipitated. The expression of Vpr prevented the coimmunoprecipitation (Fig. 4E) . These data suggest that Vpr interferes with the interaction of DDB1 with DDB2.
The Interaction of Vpr with DDB1 May Cause G2 Arrest and Apoptosis.
To determine whether Vpr induces apoptosis via DDB1, we tested the proapoptotic activity of L64P Vpr. HeLa cells were transfected with expression vector encoding wild-type or L64P HA-Vpr. Three days later, the extent of apoptosis was determined by TUNEL and G 2 arrest was measured by DNA content. Wild-type Vpr induced G 2 arrest and induced apoptosis in 40-50% of cells. In contrast, L64P Vpr did not induce apoptosis (Fig. 5A ) or G 2 arrest (Fig. 5B) . To further support these findings, we determined the effect of DDB1 knockdown on cell-cycle progression and apoptosis. DDB1 was knocked down in HeLa cells and the cells were retransfected with Vpr expres- sion vector. In the absence of Vpr, knockdown of DDB1 itself caused the cells to arrest in G 2 /M (Fig. 5C ). In addition, knockdown of Vpr largely prevented Vpr-induced apoptosis (Fig. 5D ). Microscopic inspection of the culture supported the TUNEL results. Cells that expressed Vpr were apoptotic in appearance. Apoptosis was almost completely prevented by knockdown of DDB1 (data not shown).
Discussion
Several lines of evidence suggest that the interaction with DDB1 is physiologically significant. First, a Vpr point mutant that failed to bind DDB1 failed to induce G 2 arrest and apoptosis. Second, knockdown of DDB1 prevented Vpr-induced UNG2 degradation. Third, Vpr binding to DDB1 interfered with the repair of UV-damaged DNA. Fourth, the interaction with DDB1 was conserved in SIV Vpr. Fifth, knockdown of DDB1 results in G 2 arrest, a phenotype that is also induced by Vpr. Our findings suggest a model in which Vpr activates the degradation of cellular substrates by hijacking an E3 ubiquitin ligase containing DDB1-Cul4A-Roc1 (SI Fig. 9) . Our results present a potential explanation for several of the known cellular functions of Vpr. In the cell, Vpr induces a response that mimics the response to DNA damage in which ATR is activated to phosphorylate Chk1 and nuclear ␥H2AX and 53BP1 foci form (9) (10) (11) (12) . The interaction of Vpr with DDB1 could cause the accumulation of damaged DNA by preventing DNA repair. The damaged DNA could trigger activation of ATR and the subsequent downstream effects. The failure of DDB1 to bind DNA and mediate the repair of DNA lesions generated during S phase might be sensed by the cell as DNA damage and would activate ATR, resulting in G 2 arrest followed by apoptosis.
Interestingly, a viral connection to DDB1 has been described. Paramyxoviruses such as SV5, mumps and human parainfluenza virus type 2 encode regulatory proteins that interact with DDB1 (16) (17) (18) . The paramyxovirus V protein hijacks DDB1-Cul4A to target STAT2 for proteasomal degradation, interfering with the induction of IFN response genes (27) (28) (29) (30) . Vpr is also similar to the X protein of hepatitis B virus (HBX) and V, both of which slow or arrest the cell cycle, induce a DNA damage response and cause global alterations in cellular transcription (31) (32) (33) . HBX, like Vpr, induces apoptosis through its interaction with DDB1 (32, (34) (35) (36) . Like Vpr, HBX and SV5-V disrupt the UV-DDB complex (31, 32) . Whether the interaction of Vpr with DDB1 causes the degradation of STAT proteins remains to be determined, although in a preliminary experiment, we did not detect decreased steady-state expression of STATs upon Vpr expression in HeLa cells (data not shown).
Our findings also present a second potential explanation for G 2 cell-cycle arrest. The DDB1-Cul4A ubiquitin ligase targets several proteins involved in cell-cycle regulation for proteasomal degradation including Cdt1 and p27 kip (20, 21) . Vpr could cause G 2 arrest by interfering with the degradation of proteins that regulate cell-cycle progression. This possibility would be consistent with our finding that DDB1 knockdown caused G 2 arrest. To test this model, we overexpressed DDB1 in cells that expressed limiting amounts of Vpr. However, Vpr overexpression did not abrogate Vpr-induced G 2 arrest (data not shown). In addition to DDB1, the TAP analysis identified VprBP (19) . Interestingly, VprBP was recently identified as a binding partner for DDB1. VprBP was proposed to be a member of a novel class of DDB1-Cul4A associated WD40 domain proteins (DCAF) that may be substrates for the DDB1-Cul4A E3 ubiquitin ligase (21, 37) . Our findings do not distinguish between direct binding of DDB1 to Vpr or bridging through VprBP.
The findings presented here provide an important clue toward understanding the role of Vpr in HIV-1 replication. They suggest that Vpr mediates some, if not all of its biological activities through its interaction with DDB1. How these functions promote HIV-1 replication remains to be determined. These findings raise interesting possibilities regarding the role of Vpr in HIV-1 replication that can be experimentally addressed.
Materials and Methods
pcHA-Vpr expresses an N-terminal HA-tagged NL4-3 Vpr in the cytomegalovirus promoter driven vector pcDNAI/amp (Invitrogen). The L64P mutation was introduced by site-directed mutagenesis. 3X-Flag-DDB2 expression vector was a gift from Hitoshi Endo (38) . The T7-DDB1 expression vector was provided by P. R. Raychaudhuri. The T7 tag was replaced with a myc-tag by PCR, and the W561A mutation was introduced by site-directed mutagenesis. NTAP-Vpr was generated by subcloning Vpr from pcHA-Vpr into the pNTAP (Stratagene) at the Bam-HI and HindIII sites. UNG2 and SMUG1 expression vectors have been reported (8) . pNL43(HA-Vpr) was constructed by inserting a HindIII site at the start codon of vpr of pNL43. pNL43 was than cleaved with HindIII and at the unique EcoRI site in vpr, and the resulting fragment was replaced with a HindIII/EcoRI fragment from pcHA-Vpr. The modification does not interfere with virus replication in T cell lines.
Additional experimental methods are in SI Materials and Methods.
